References
- Seymen P, Aytac E, Esen F, Darbepoetin alpha ameliorates neuronal damage in a rat model of acute ethanol intoxication. Int J Neurosci 2012 (in press).
- Kanaan NM, Collier TJ, Marchionini DM, Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease. Brain Res 2006;1068:221–9.
- Pedroso I, Bringas ML, Aguiar A, Use of Cuban recombinant human erythropoietin in Parkinson's disease treatment. MEDICC Rev 2012;14:11–7.
- Ganser C, Papazoglou A, Just L, Nikkhah G. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures. Exp Cell Res 2010;316:737–46.
- Wu Y, Shang Y, Sun S, Liu R. Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. Eur J Pharmacol 2007;564:47–56.
- Xue YQ, Ma BF, Zhao LR, AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease. Gene Ther 2010;17:83–94.
- Shang YC, Chong ZZ, Wang S, Maiese K. Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL. Albany, NY: Aging; 2012;4:187–201.
- Assaraf MI, Diaz Z, Liberman A, Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol 2007;66:389–98.
- Chong ZZ, Li F, Maiese K. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2005;2:387–99.
- Ehrenreich H, Fischer B, Norra C, Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007;130:2577–88.